Similar articles

• Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.

  Clumeck N, Wit SD, Hermans P, Franchioly P, Sommereijns B. Clumeck N, et al. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:353-6. doi: 10.3177/jnsv.38.special_353. J Nutr Sci Vitaminol (Tokyo). 1992. PMID: 1284305 Clinical Trial. No abstract available.
• Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.

  van der Wouw PA, van Leeuwen R, van Oers RH, Lange JM, Danner SA. van der Wouw PA, et al. Br J Haematol. 1991 Jul;78(3):319-24. doi: 10.1111/j.1365-2141.1991.tb04443.x. Br J Haematol. 1991. PMID: 1714756
• [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].

  Garavelli PL, Berti P. Garavelli PL, et al. Recenti Prog Med. 1993 Jul-Aug;84(7-8):526-30. Recenti Prog Med. 1993. PMID: 8356307 Italian.
• [Treatment of neutropenia in HIV infection with hematopoietic growth factors].

  Moreno García M, Fernández González F. Moreno García M, et al. Rev Clin Esp. 1996 Apr;196(4):248-54. Rev Clin Esp. 1996. PMID: 8701065 Review. Spanish. No abstract available.
• Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.

  Hewitt RG, Morse GD. Hewitt RG, et al. Pharmacotherapy. 1992;12(6):455-61. Pharmacotherapy. 1992. PMID: 1492010 Review.